Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 7/20 | 0.37 |
| ▸ | CPB1 | P15086 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11301850 | 1.00 | CPB2 (0.37) | CPB2CPB1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL933574 | 1.00 | CPB2 (0.37) | CPB2CPB1ALDH1A1CYP1A2CYP3A4 | |
| Fluoride SCHEMBL27998040 | 0.98 | CPB2 (0.36) | CPB2CPB1 | |
| Hydrochloric Acid SCHEMBL10980804 | 0.98 | CPB2 (0.36) | CPB2CPB1 | |
| Hydrochloric Acid SCHEMBL10981835 | 0.98 | CPB2 (0.36) | CPB2CPB1 | |
| Hydrochloric Acid SCHEMBL10976751 | 0.98 | CPB2 (0.36) | CPB2CPB1 | |
| Hydrochloric Acid SCHEMBL9186803 | 0.97 | CPB2 (0.36) | CPB2CPB1 | |
| SCHEMBL15665199 | 0.93 | CPB2 (0.36) | CPB2CPB1 | |
| SCHEMBL5984088 | 0.91 | TNF (0.41) | CPB2CPB1ALDH1A1 | |
| Tetrahydrofuran SCHEMBL10977306 | 0.90 | CPB2 (0.32) | CPB2CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1703 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250197916-A1 | METHODS AND COMPOSITIONS FOR SUPPRESSION OF BIOGENIC AMINES PRODUCED BY THE GUT MICROBIOME | CEDARS-SINAI MEDICAL CENTER (US) | 2025-06-19 | — | — | US | claimed |
| EP-3891176-B1 | DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE | HOLST BIRGITTE (DK) | 2024-06-05 | — | — | EP | claimed |
| CN-117778530-A | Method for adding preset joint to 5' end of single-stranded DNA | 清华大学 | 2024-03-29 | — | — | CN | claimed |
| EP-3250191-B1 | TABLETS COMPRISING GLP-1 AGONIST AND ENTERIC COATING | NOVO NORDISK AS (DK) | 2024-01-17 | — | — | EP | claimed |
| EP-3077008-B1 | BIOREVERSABLE PROMOIETIES FOR NITROGEN-CONTAINING AND HYDROXYL-CONTAINING DRUGS | HAN JIE (CN) | 2023-10-04 | — | — | EP | claimed |
| US-20230043198-A1 | MICROBIOTA METABOLITES THAT SHAPE HOST PHYSIOLOGY | YALE UNIVERSITY (US) | 2023-02-09 | — | — | US | claimed |
| CN-112043835-B | Bioreversible introducing group for nitrogen and hydroxyl-containing drugs | 韩捷 | 2022-10-21 | — | — | CN | claimed |
| EP-2637698-B1 | DOUBLE-ACYLATED GLP-1 DERIVATIVES | NOVO NORDISK AS (DK) | 2022-04-20 | — | — | EP | claimed |
| US-20220056077-A1 | DUAL AGONIST GLP-1 AND NEUROTENSIN FUSION PEPTIDE | RATNER, Cecilia (DK) | 2022-02-24 | — | — | US | claimed |
| CN-107205948-B | Tablets comprising a GLP-1 agonist and an enteric coating | 诺和诺德股份有限公司 | 2021-12-14 | — | — | CN | claimed |
| WO-1996026712-A2 | USE OF ANGIOGENESIS SUPPRESSORS FOR INHIBITING HAIR GROWTH | HANDELMAN, JOSEPH, H. (US) | 1996-09-06 | — | — | WO | claimed |
| EP-0180597-B1 | COUGH/COLD MIXTURES COMPRISING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | RICHARDSON-VICKS, INC. (US) | 1992-03-04 | — | — | EP | claimed |
| US-4876246-A | Benzo[a]phenothiazines and hydro-derivatives for inhibiting leukotriene biosynthesis | MERCK FROSST CANADA, INC. (CA) | 1989-10-24 | — | — | US | claimed |
| EP-0109036-B1 | ANTI-INFLAMMATORY/ANALGESIC COMBINATION OF ALPHA-FLUOROMETHYLHISTIDINE AND A SELECTED NON-STEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) | MERCK & CO. INC. (US) | 1987-09-02 | — | — | EP | claimed |
| EP-0073971-B1 | THIADIAZOLE OXIDES AS GASTRIC ANTISECRETORY AGENTS | MERCK & CO. INC. (US) | 1986-05-21 | — | — | EP | claimed |
| US-4522823-A | Orexigenic use of α-fluoromethyl-histidine | MERCK & CO., INC. (US) | 1985-06-11 | — | — | US | claimed |
| EP-0109036-A1 | Anti-inflammatory/analgesic combination of alpha-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID) | MERCK & CO. INC. (US) | 1984-05-23 | — | — | EP | claimed |
| US-4447443-A | SYNERGISTIC MIXTURE | MERCK & CO., INC. (US) | 1984-05-08 | — | — | US | claimed |
| US-4411899-A | Substituted derivatives of amino alkane diols as gastric secretion inhibitors | MERCK & CO., INC. (US) | 1983-10-25 | — | — | US | claimed |
| EP-0082376-A2 | Substituted derivatives of amino alkane diols as gastric secretion inhibitors | MERCK & CO. INC. (US) | 1983-06-29 | — | — | EP | claimed |